Here are relevant reports on : cord-blood-banking-market
-
Retail Banking Trends
An increasing focus on customer relationship management and on providing user-friendly banking solutions have been the latest trends in the retail banking sector. The introduction of internet and mobile banking services has also fueled the growth of retail banking. This research report will analyze these and other developments such as outsourcing backend operations. It will also identify the services of and the growth strategies adopted by the leading banks in the retail banking sector.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Food Intolerance Test Market by Test Type (Conventional (Skin (Scratch, Intradermal, Patch), Blood (Elisa, Rast)), Alternative Allergy (Non Invasive (Hair, Kinesiology), Invasive (Igg Blood, Electro-Dermal, Cytotoxic, Microarray))) - Global Forecast to 2020
Food intolerance is a non-allergic hypersensitivity to a food product. It is caused when an incompletely digested food enters into a bloodstream. It is usually either due to lack of required enzyme to digest food or inability to absorb a digested food. Food intolerance testing is needed to assess digestion capability and suggest appropriate diet.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024
The global patient blood management market size is expected to grow USD 15.3 billion by 2024, at a CAGR of 7.4% during the forecasting period. The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) - Global Forecast to 2030
The global blood gas analyzer market, valued at US$2.61 billion in 2024, stood at US$2.70 billion in 2025 and is projected to advance at a resilient CAGR of 4.6% from 2024 to 2030, culminating in a forecasted valuation of US$3.38 billion by the end of the period. Growth is being driven by the rising prevalence of chronic and acute diseases, increasing demand for rapid and accurate diagnostics, and continuous advancements in blood gas analyzer technology.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028
The global blood screening market, valued at US$2.3 billion in 2022, stood at US$2.4 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.4 billion by the end of the period. The need for blood is ever-increasing, forcing the number of blood donations to rise as well throughout the world. Combining this factor along with the growing infectious diseases is the major contributor for the growing blood screening market.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type (Blood, Cervical, Nasal, Nasopharyngeal, Throat, Oral), Region - Global Forecast to 2026
The global Virology Specimen Collection Market boasts a total value of $5.6 billion in 2021 and is projected to register a growth rate of -0.6% to reach a value of $5.4 billion by 2026. The major players operating in this market are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific, Inc. (US), Trinity Biotech (Ireland), Titan Biotech, Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.p.A. (Italy), Puritan Medical Products, Co. (Guilford, ME) and Hardy Diagnostics (US).
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Neurosurgery Devices Market by Product (Neuromodulation(Spinal Cord Stimulation, Deep Brain Stimulation) Neuroendoscopy), Application (Chronic Pain, Depression, Parkinsons, Ischemia, Transnasal Neuroendoscopy), Region - Global Forecast to 2024
The Neurosurgery Devices Market is expected to grow from USD 7.3 billion in 2019 to USD 13.5 billion by 2024, at a CAGR of 13.0% during the forecast period. Major players operating in the neurosurgery devices market include B. Braun Melsungen (Germany), Medtronic (US), Boston Scientific Corporation (US), Nevro Corporation (US), KARL STORZ (Germany), Abbott (US), Ackermann Instrumente (Germany), Hawk (China), Machida Endoscope (Japan), and adeor Medical (Germany).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Orthopedic Surgery Equipment Market by Product (Spinal Cord, Knee & Hip Replacement, Shoulder), End User (Hospitals, Ambulatory Surgery Center) - Global Forecast to 2022
The global orthopedic surgery equipment market is expected to reach USD 22.8 Billion by 2022 from USD 17.5 Billion in 2017, growing at a CAGR of 5.5% from 2017 to 2022. Rising incidence and prevalence of orthopedic disorders, and growing geriatric population are some of the major driving factors driving the growth of the global orthopedic surgery equipment market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
